Clinical Trials Browser

Not yet recruiting × Radiation Dose Hypofractionation × 90 days × Clear all

NCT07507058 2026-04-02

Hypofractionated Radiotherapy for Postoperative Intermediate-Risk Head and Neck Squamous Cell Carcinoma

Phase NA Not yet recruiting

Squamous Cell Carcinoma of Head and Neck

NCT07358676 2026-01-22

A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma